Orthofix Medical Inc (OFIX)
13.26
-0.22
(-1.63%)
USD |
NASDAQ |
Jun 28, 16:00
13.24
-0.02
(-0.15%)
After-Hours: 20:00
Orthofix Medical Research and Development Expense (TTM): 76.42M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 76.42M |
| December 31, 2023 | 80.23M |
| September 30, 2023 | 74.44M |
| June 30, 2023 | 67.83M |
| March 31, 2023 | 61.16M |
| December 31, 2022 | 49.06M |
| September 30, 2022 | 49.16M |
| June 30, 2022 | 49.57M |
| March 31, 2022 | 49.94M |
| December 31, 2021 | 49.62M |
| September 30, 2021 | 46.74M |
| June 30, 2021 | 44.34M |
| March 31, 2021 | 39.99M |
| December 31, 2020 | 39.06M |
| September 30, 2020 | 37.14M |
| June 30, 2020 | 35.16M |
| March 31, 2020 | 35.37M |
| December 31, 2019 | 34.64M |
| September 30, 2019 | 34.98M |
| June 30, 2019 | 36.60M |
| March 31, 2019 | 35.51M |
| December 31, 2018 | 33.22M |
| September 30, 2018 | 32.88M |
| June 30, 2018 | 30.22M |
| March 31, 2018 | 29.21M |
| Date | Value |
|---|---|
| December 31, 2017 | 29.70M |
| September 30, 2017 | 28.76M |
| June 30, 2017 | 28.68M |
| March 31, 2017 | 28.59M |
| December 31, 2016 | 28.80M |
| September 30, 2016 | 28.86M |
| June 30, 2016 | 28.53M |
| March 31, 2016 | 28.18M |
| December 31, 2015 | 26.39M |
| September 30, 2015 | 25.00M |
| June 30, 2015 | 25.04M |
| March 31, 2015 | 24.91M |
| December 31, 2014 | 24.99M |
| September 30, 2014 | 24.93M |
| June 30, 2014 | 24.72M |
| March 31, 2014 | 26.96M |
| December 31, 2013 | 26.77M |
| September 30, 2013 | 26.07M |
| June 30, 2013 | 26.57M |
| March 31, 2013 | 27.27M |
| December 31, 2012 | 28.58M |
| September 30, 2012 | 28.37M |
| June 30, 2012 | 27.49M |
| March 31, 2012 | 24.47M |
| December 31, 2011 | 23.47M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
34.64M
Minimum
Dec 2019
80.23M
Maximum
Dec 2023
50.26M
Average
49.06M
Median
Dec 2022
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.444B |
| Perspective Therapeutics Inc | 24.91M |
| Xtant Medical Holdings Inc | 1.689M |
| Asensus Surgical Inc | 34.98M |
| Catheter Precision Inc | 0.272M |